The information presented indicates that circulating HGF and MET levels, MET protein expression levels in tumor tissues, and MET gene amplification, copy number and mutation, as well as markers related to crosstalk of related pathways, are commonly evaluated biomarkers. Here, MET is linked to neoplasm.